February 28, 2012 9:19 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Benchmark raises its price target on Buy-rated eResearch Technology (NASDAQ: ERT) to reflect the company's expanding capacity and efficiency. Benchmark comments, "ERT posted strong Q4 results including revenue growth of 16.5% to $52.3 million, and $0.14 non-GAAP EPS. Results widely exceeded the consensus forecast of $47.5 million revenue and $0.10 EPS, benefiting from approximately $2 million in accelerated Thorough ECG revenue. We believe underlying clinical research industry trends recovered late in 2011 and have returned to a favorable track. We believe ERT's launch of the Expert3 workflow management system in January 2012 positions it well to accept additional workload and simultaneously increase efficiency."ERT closed at $5.57 a share on Monday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.